| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |